SARS-CoV-2 VLPs B.1.1.7 (Alpha) Ver mas grande

SARS-CoV-2 virus-like particles B.1.1.7 (Alpha) are composed of four structural proteins: Membrane protein (M), Nucleocapsid pro

AB-P7037

Producto nuevo

SARS-CoV-2 VLPs B.1.1.7 (Alpha)

Más detalles

Por favor regístrese para ver el precio

Comprando este producto generará 7 Biopuntos. Su cesta contiene un total 7 Biopuntos puede ser convertido en un Biobonos Descuento 28.00EUR.


Hoja técnica

Size 100 ug
Storage Conditions Store at 4ºC. For long term storage store at -80ºC.<br>Aliquot to avoid repeated freezing and thawing.
Application Key WB
Form Liquid
Recomended Dilution SDS-PAGE<br>The optimal working dilution should be determined by the end user.
Storage Buffer In PBS, pH7.4.

Más información

SARS-CoV-2 virus-like particles B.1.1.7 (Alpha) are composed of four structural proteins: Membrane protein (M), Nucleocapsid protein (N), Alpha-spike protein (S) and Envelope protein (E).

Consulta sobre un producto

SARS-CoV-2 virus-like particles B.1.1.7 (Alpha) are composed of four structural proteins: Membrane protein (M), Nucleocapsid pro

SARS-CoV-2 virus-like particles B.1.1.7 (Alpha) are composed of four structural proteins: Membrane protein (M), Nucleocapsid pro